M & As this week: Chengdu Kanghong Pharmaceutical, Cachet Pharmaceutical, Antegrin Therapeutics

Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group has announced its intention to acquire the remaining 7% stake in a pharmaceutical unit based in Chengdu, China.

Source: Drug Development Technology - October 20, 2016 Category: Pharmaceuticals Source Type: news